SCM
RNXT icon

Stonepine Capital Management’s RenovoRx RNXT Stock Holding History

Stonepine Capital Management’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-278,188
Closed -$275K – 80
2025
Q1 		$275K Buy
+278,188
New +$324K 0.27% 45

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Stonepine Capital Management's RNXT Position: Q2 2025 in Review

Stonepine Capital Management sold out of RenovoRx (RNXT) in Q2 2025, closing a stake of 278,188 shares — an estimated $275K sold.

Stonepine Capital Management first reported a position in RNXT in Q1 2025 and held it in 1 quarter. The position peaked at $275K in Q1 2025. 25 funds tracked by Wall St. Rank hold RNXT as of Q2 2025.

  • Stonepine Capital Management reported no remaining RenovoRx position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 278,188 RenovoRx shares in Q2 2025, an estimated $275K.
  • Stonepine Capital Management first reported a position in RenovoRx in Q1 2025 and held it in 1 quarter.
  • Stonepine Capital Management's RenovoRx position peaked at $275K in Q1 2025.
  • 25 funds tracked by Wall St. Rank held RenovoRx as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.